We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04484012
Brief Title: Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

First Submitted : July 7, 2020
First Submitted that Met QC Criteria : July 21, 2020
First Posted : July 23, 2020

Last Update Submitted that Met QC Criteria : June 16, 2022
Last Update Posted : June 21, 2022